The table below shows BELITE BIO, INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$36.99M
-$29.23M
-$29.84M
-$11.46M
-$7.47M
-$4.44M
Capital expenditure
$71.00K
$116.00K
$63.00K
$394.00K
$74.00K
-
Investing cash flow
-$305.11M
-$110.57M
-$63.00K
-$394.00K
-$56.00K
-$20.00K
Dividends paid
-
-
-
-
BLTE operating cash flow (10-K history)
BELITE BIO, INC reported operating cash flow of -$36.99M for fiscal year 2025. That is down 26.5% from -$29.23M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$4.44M (FY 2020) to -$36.99M. Figures come from the company's audited annual reports as filed with the SEC.